---
document_datetime: 2025-12-02 05:27:31
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/refludan.html
document_name: refludan.html
version: success
processing_time: 0.1023204
conversion_datetime: 2025-12-28 18:14:49.172358
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# Refludan

[RSS](/en/individual-human-medicine.xml/66869)

##### Withdrawn

This medicine's authorisation has been withdrawn

lepirudin Medicine Human Withdrawn

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)
- [Assessment history](#assessment-history)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

On 13 March 1997 the European Commission issued a marketing authorisation valid throughout the European Union for the medicinal product Refludan (lepirudin). Refludan was approved for anticoagulation in adult patients with heparin-induced thrombocytopenia (HAT) type II and thromboembolic disease mandating parenteral antithrombotic therapy. The marketing authorisation holder (MAH) responsible for Refludan was Celgene Europe Ltd. The European Commission was notified by 3 letters dated 31 March 2012, 2 April 2012 and 30 April 2012 of the MAH's decision to voluntarily withdraw the marketing authorisation for Refludan for commercial reasons.

On 24 April 2012 the European Commission issued a decision to withdraw the marketing authorisation for Refludan. Pursuant to this decision the European Public Assessment Report for Refludan is updated to reflect the fact that the marketing authorisation is no longer valid.

Refludan : EPAR - Summary for the public

English (EN) (262.17 KB - PDF)

**First published:** 27/04/2009

**Last updated:** 27/07/2012

[View](/en/documents/overview/refludan-epar-summary-public_en.pdf)

[Other languages (21)](#file-language-dropdown-358)

български (BG) (429.25 KB - PDF)

**First published:**

27/04/2009

**Last updated:**

27/07/2012

[View](/bg/documents/overview/refludan-epar-summary-public_bg.pdf)

español (ES) (264.03 KB - PDF)

**First published:**

27/04/2009

**Last updated:**

27/07/2012

[View](/es/documents/overview/refludan-epar-summary-public_es.pdf)

čeština (CS) (400.71 KB - PDF)

**First published:**

27/04/2009

**Last updated:**

27/07/2012

[View](/cs/documents/overview/refludan-epar-summary-public_cs.pdf)

dansk (DA) (262.07 KB - PDF)

**First published:**

27/04/2009

**Last updated:**

27/07/2012

[View](/da/documents/overview/refludan-epar-summary-public_da.pdf)

Deutsch (DE) (263.26 KB - PDF)

**First published:**

27/04/2009

**Last updated:**

27/07/2012

[View](/de/documents/overview/refludan-epar-summary-public_de.pdf)

eesti keel (ET) (262.89 KB - PDF)

**First published:**

27/04/2009

**Last updated:**

27/07/2012

[View](/et/documents/overview/refludan-epar-summary-public_et.pdf)

ελληνικά (EL) (398.18 KB - PDF)

**First published:**

27/04/2009

**Last updated:**

27/07/2012

[View](/el/documents/overview/refludan-epar-summary-public_el.pdf)

français (FR) (265.03 KB - PDF)

**First published:**

27/04/2009

**Last updated:**

27/07/2012

[View](/fr/documents/overview/refludan-epar-summary-public_fr.pdf)

italiano (IT) (264.33 KB - PDF)

**First published:**

27/04/2009

**Last updated:**

27/07/2012

[View](/it/documents/overview/refludan-epar-summary-public_it.pdf)

latviešu valoda (LV) (406.2 KB - PDF)

**First published:**

27/04/2009

**Last updated:**

27/07/2012

[View](/lv/documents/overview/refludan-epar-summary-public_lv.pdf)

lietuvių kalba (LT) (379.07 KB - PDF)

**First published:**

27/04/2009

**Last updated:**

27/07/2012

[View](/lt/documents/overview/refludan-epar-summary-public_lt.pdf)

magyar (HU) (392.49 KB - PDF)

**First published:**

27/04/2009

**Last updated:**

27/07/2012

[View](/hu/documents/overview/refludan-epar-summary-public_hu.pdf)

Malti (MT) (403.96 KB - PDF)

**First published:**

27/04/2009

**Last updated:**

27/07/2012

[View](/mt/documents/overview/refludan-epar-summary-public_mt.pdf)

Nederlands (NL) (264.24 KB - PDF)

**First published:**

27/04/2009

**Last updated:**

27/07/2012

[View](/nl/documents/overview/refludan-epar-summary-public_nl.pdf)

polski (PL) (409.22 KB - PDF)

**First published:**

27/04/2009

**Last updated:**

27/07/2012

[View](/pl/documents/overview/refludan-epar-summary-public_pl.pdf)

português (PT) (264.41 KB - PDF)

**First published:**

27/04/2009

**Last updated:**

27/07/2012

[View](/pt/documents/overview/refludan-epar-summary-public_pt.pdf)

română (RO) (371.68 KB - PDF)

**First published:**

27/04/2009

**Last updated:**

27/07/2012

[View](/ro/documents/overview/refludan-epar-summary-public_ro.pdf)

slovenčina (SK) (396.91 KB - PDF)

**First published:**

27/04/2009

**Last updated:**

27/07/2012

[View](/sk/documents/overview/refludan-epar-summary-public_sk.pdf)

slovenščina (SL) (387.06 KB - PDF)

**First published:**

27/04/2009

**Last updated:**

27/07/2012

[View](/sl/documents/overview/refludan-epar-summary-public_sl.pdf)

Suomi (FI) (263.77 KB - PDF)

**First published:**

27/04/2009

**Last updated:**

27/07/2012

[View](/fi/documents/overview/refludan-epar-summary-public_fi.pdf)

svenska (SV) (264.23 KB - PDF)

**First published:**

27/04/2009

**Last updated:**

27/07/2012

[View](/sv/documents/overview/refludan-epar-summary-public_sv.pdf)

## Product information

Refludan : EPAR - Product Information

English (EN) (681.95 KB - PDF)

**First published:** 27/04/2009

**Last updated:** 27/07/2012

[View](/en/documents/product-information/refludan-epar-product-information_en.pdf)

[Other languages (23)](#file-language-dropdown-428)

български (BG) (1.53 MB - PDF)

**First published:**

27/04/2009

**Last updated:**

27/07/2012

[View](/bg/documents/product-information/refludan-epar-product-information_bg.pdf)

español (ES) (703.63 KB - PDF)

**First published:**

27/04/2009

**Last updated:**

27/07/2012

[View](/es/documents/product-information/refludan-epar-product-information_es.pdf)

čeština (CS) (1.18 MB - PDF)

**First published:**

27/04/2009

**Last updated:**

27/07/2012

[View](/cs/documents/product-information/refludan-epar-product-information_cs.pdf)

dansk (DA) (696.12 KB - PDF)

**First published:**

27/04/2009

**Last updated:**

27/07/2012

[View](/da/documents/product-information/refludan-epar-product-information_da.pdf)

Deutsch (DE) (729.75 KB - PDF)

**First published:**

27/04/2009

**Last updated:**

27/07/2012

[View](/de/documents/product-information/refludan-epar-product-information_de.pdf)

eesti keel (ET) (742.82 KB - PDF)

**First published:**

27/04/2009

**Last updated:**

27/07/2012

[View](/et/documents/product-information/refludan-epar-product-information_et.pdf)

ελληνικά (EL) (925.35 KB - PDF)

**First published:**

27/04/2009

**Last updated:**

27/07/2012

[View](/el/documents/product-information/refludan-epar-product-information_el.pdf)

français (FR) (806.43 KB - PDF)

**First published:**

27/04/2009

**Last updated:**

27/07/2012

[View](/fr/documents/product-information/refludan-epar-product-information_fr.pdf)

íslenska (IS) (698.12 KB - PDF)

**First published:**

27/04/2009

**Last updated:**

27/07/2012

[View](/is/documents/product-information/refludan-epar-product-information_is.pdf)

italiano (IT) (763.73 KB - PDF)

**First published:**

27/04/2009

**Last updated:**

27/07/2012

[View](/it/documents/product-information/refludan-epar-product-information_it.pdf)

latviešu valoda (LV) (1.23 MB - PDF)

**First published:**

27/04/2009

**Last updated:**

27/07/2012

[View](/lv/documents/product-information/refludan-epar-product-information_lv.pdf)

lietuvių kalba (LT) (828.11 KB - PDF)

**First published:**

27/04/2009

**Last updated:**

27/07/2012

[View](/lt/documents/product-information/refludan-epar-product-information_lt.pdf)

magyar (HU) (1.17 MB - PDF)

**First published:**

27/04/2009

**Last updated:**

27/07/2012

[View](/hu/documents/product-information/refludan-epar-product-information_hu.pdf)

Malti (MT) (1.25 MB - PDF)

**First published:**

27/04/2009

**Last updated:**

27/07/2012

[View](/mt/documents/product-information/refludan-epar-product-information_mt.pdf)

Nederlands (NL) (710.35 KB - PDF)

**First published:**

27/04/2009

**Last updated:**

27/07/2012

[View](/nl/documents/product-information/refludan-epar-product-information_nl.pdf)

norsk (NO) (729.88 KB - PDF)

**First published:**

27/04/2009

**Last updated:**

27/07/2012

[View](/no/documents/product-information/refludan-epar-product-information_no.pdf)

polski (PL) (1.24 MB - PDF)

**First published:**

27/04/2009

**Last updated:**

27/07/2012

[View](/pl/documents/product-information/refludan-epar-product-information_pl.pdf)

português (PT) (694.29 KB - PDF)

**First published:**

27/04/2009

**Last updated:**

27/07/2012

[View](/pt/documents/product-information/refludan-epar-product-information_pt.pdf)

română (RO) (864.44 KB - PDF)

**First published:**

27/04/2009

**Last updated:**

27/07/2012

[View](/ro/documents/product-information/refludan-epar-product-information_ro.pdf)

slovenčina (SK) (1.21 MB - PDF)

**First published:**

27/04/2009

**Last updated:**

27/07/2012

[View](/sk/documents/product-information/refludan-epar-product-information_sk.pdf)

slovenščina (SL) (1.15 MB - PDF)

**First published:**

27/04/2009

**Last updated:**

27/07/2012

[View](/sl/documents/product-information/refludan-epar-product-information_sl.pdf)

Suomi (FI) (673.54 KB - PDF)

**First published:**

27/04/2009

**Last updated:**

27/07/2012

[View](/fi/documents/product-information/refludan-epar-product-information_fi.pdf)

svenska (SV) (659.25 KB - PDF)

**First published:**

27/04/2009

**Last updated:**

27/07/2012

[View](/sv/documents/product-information/refludan-epar-product-information_sv.pdf)

**Latest procedure affecting product information:** T/0038 24/04/2012

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

Refludan : EPAR - All Authorised presentations

English (EN) (263.62 KB - PDF)

**First published:** 10/07/2006

**Last updated:** 27/07/2012

[View](/en/documents/all-authorised-presentations/refludan-epar-all-authorised-presentations_en.pdf)

[Other languages (23)](#file-language-dropdown-12)

български (BG) (322.63 KB - PDF)

**First published:**

10/07/2006

**Last updated:**

27/07/2012

[View](/bg/documents/all-authorised-presentations/refludan-epar-all-authorised-presentations_bg.pdf)

español (ES) (271.5 KB - PDF)

**First published:**

10/07/2006

**Last updated:**

27/07/2012

[View](/es/documents/all-authorised-presentations/refludan-epar-all-authorised-presentations_es.pdf)

čeština (CS) (295.93 KB - PDF)

**First published:**

10/07/2006

**Last updated:**

27/07/2012

[View](/cs/documents/all-authorised-presentations/refludan-epar-all-authorised-presentations_cs.pdf)

dansk (DA) (268.04 KB - PDF)

**First published:**

10/07/2006

**Last updated:**

27/07/2012

[View](/da/documents/all-authorised-presentations/refludan-epar-all-authorised-presentations_da.pdf)

Deutsch (DE) (270.64 KB - PDF)

**First published:**

10/07/2006

**Last updated:**

27/07/2012

[View](/de/documents/all-authorised-presentations/refludan-epar-all-authorised-presentations_de.pdf)

eesti keel (ET) (264.04 KB - PDF)

**First published:**

10/07/2006

**Last updated:**

27/07/2012

[View](/et/documents/all-authorised-presentations/refludan-epar-all-authorised-presentations_et.pdf)

ελληνικά (EL) (286.07 KB - PDF)

**First published:**

10/07/2006

**Last updated:**

27/07/2012

[View](/el/documents/all-authorised-presentations/refludan-epar-all-authorised-presentations_el.pdf)

français (FR) (272.13 KB - PDF)

**First published:**

10/07/2006

**Last updated:**

27/07/2012

[View](/fr/documents/all-authorised-presentations/refludan-epar-all-authorised-presentations_fr.pdf)

íslenska (IS) (267.72 KB - PDF)

**First published:**

10/07/2006

**Last updated:**

27/07/2012

[View](/is/documents/all-authorised-presentations/refludan-epar-all-authorised-presentations_is.pdf)

italiano (IT) (270.35 KB - PDF)

**First published:**

10/07/2006

**Last updated:**

27/07/2012

[View](/it/documents/all-authorised-presentations/refludan-epar-all-authorised-presentations_it.pdf)

latviešu valoda (LV) (297.31 KB - PDF)

**First published:**

10/07/2006

**Last updated:**

27/07/2012

[View](/lv/documents/all-authorised-presentations/refludan-epar-all-authorised-presentations_lv.pdf)

lietuvių kalba (LT) (285.95 KB - PDF)

**First published:**

10/07/2006

**Last updated:**

27/07/2012

[View](/lt/documents/all-authorised-presentations/refludan-epar-all-authorised-presentations_lt.pdf)

magyar (HU) (285.79 KB - PDF)

**First published:**

10/07/2006

**Last updated:**

27/07/2012

[View](/hu/documents/all-authorised-presentations/refludan-epar-all-authorised-presentations_hu.pdf)

Malti (MT) (314.97 KB - PDF)

**First published:**

10/07/2006

**Last updated:**

27/07/2012

[View](/mt/documents/all-authorised-presentations/refludan-epar-all-authorised-presentations_mt.pdf)

Nederlands (NL) (264.39 KB - PDF)

**First published:**

10/07/2006

**Last updated:**

27/07/2012

[View](/nl/documents/all-authorised-presentations/refludan-epar-all-authorised-presentations_nl.pdf)

norsk (NO) (266.44 KB - PDF)

**First published:**

10/07/2006

**Last updated:**

27/07/2012

[View](/no/documents/all-authorised-presentations/refludan-epar-all-authorised-presentations_no.pdf)

polski (PL) (300.21 KB - PDF)

**First published:**

10/07/2006

**Last updated:**

27/07/2012

[View](/pl/documents/all-authorised-presentations/refludan-epar-all-authorised-presentations_pl.pdf)

português (PT) (267.45 KB - PDF)

**First published:**

10/07/2006

**Last updated:**

27/07/2012

[View](/pt/documents/all-authorised-presentations/refludan-epar-all-authorised-presentations_pt.pdf)

română (RO) (295.26 KB - PDF)

**First published:**

10/07/2006

**Last updated:**

27/07/2012

[View](/ro/documents/all-authorised-presentations/refludan-epar-all-authorised-presentations_ro.pdf)

slovenčina (SK) (297.39 KB - PDF)

**First published:**

10/07/2006

**Last updated:**

27/07/2012

[View](/sk/documents/all-authorised-presentations/refludan-epar-all-authorised-presentations_sk.pdf)

slovenščina (SL) (281.9 KB - PDF)

**First published:**

10/07/2006

**Last updated:**

27/07/2012

[View](/sl/documents/all-authorised-presentations/refludan-epar-all-authorised-presentations_sl.pdf)

Suomi (FI) (262.22 KB - PDF)

**First published:**

10/07/2006

**Last updated:**

27/07/2012

[View](/fi/documents/all-authorised-presentations/refludan-epar-all-authorised-presentations_fi.pdf)

svenska (SV) (273.16 KB - PDF)

**First published:**

10/07/2006

**Last updated:**

27/07/2012

[View](/sv/documents/all-authorised-presentations/refludan-epar-all-authorised-presentations_sv.pdf)

## Product details

Name of medicine Refludan Active substance lepirudin International non-proprietary name (INN) or common name lepirudin Therapeutic area (MeSH)

- Thromboembolism
- Thrombocytopenia

Anatomical therapeutic chemical (ATC) code B01AE02

### Pharmacotherapeutic group

Antithrombotic agents

### Therapeutic indication

Anticoagulation in adult patients with heparin-induced thrombocytopenia type II and thromboembolic disease mandating parenteral antithrombotic therapy.

The diagnosis should be confirmed by the heparin-induced platelet activation assay or an equivalent test.

## Authorisation details

EMA product number EMEA/H/C/000122 Marketing authorisation holder

Celgene Europe Ltd.

Riverside House

Marketing authorisation issued 13/03/1997 Withdrawal of marketing authorisation 24/04/2012 Revision 15

## Assessment history

Expand section

Collapse section

## Changes since initial authorisation of medicine

Refludan : EPAR - Steps taken after authorisation when a cutoff date has been used

English (EN) (321.03 KB - PDF)

**First published:** 10/07/2006

**Last updated:** 27/07/2012

[View](/en/documents/steps-after-cutoff/refludan-epar-steps-taken-after-authorisation-when-cutoff-date-has-been-used_en.pdf)

## Initial marketing authorisation documents

Refludan : EPAR - Procedural steps taken before authorisation

English (EN) (318.94 KB - PDF)

**First published:** 10/07/2006

**Last updated:** 27/07/2012

[View](/en/documents/procedural-steps/refludan-epar-procedural-steps-taken-authorisation_en.pdf)

Refludan : EPAR - Scientific Discussion

English (EN) (445.89 KB - PDF)

**First published:** 10/07/2006

**Last updated:** 27/07/2012

[View](/en/documents/scientific-discussion/refludan-epar-scientific-discussion_en.pdf)

**This page was last updated on** 27/07/2012

## Share this page

[Back to top](#main-content)